SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve (i) Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2021.
(ii) recommendation of final dividend for the year ended March 31, 2021 subject to the approval of the shareholders at the ensuing 29th Annual General Meeting.